GE HealthCare to acquire remaining 50% stake in Nihon Medi-Physics (NMP), a leading radiopharmaceutical company in Japan, from Sumitomo Chemical ...

GE HealthCare (NASDAQ:GEHC) has agreed to acquire the remaining 50% stake in Nihon Medi-Physics (NMP) from Sumitomo Chemical ...

Nihon Medi-Physics, formed in 1973, operates 13 manufacturing facilities and generated about $183 million in 2023 revenue, GE HealthCare said.

GE Healthcare will acquire Nihon Medi-Physics (NMP), a Tokyo-based firm that makes radiopharmaceuticals used in imaging for neurology, cardiology and oncology procedures. · MedTech Dive ...

GE HealthCare has entered an agreement to purchase the remaining 50% stake in Nihon Medi-Physics (NMP) from Sumitomo Chemical, aiming for complete ownership. The agreement, which is set to close ...

GE HealthCare has completed its acquisition of Sumitomo Chemical’s 50% stake in Nihon Medi-Physics (NMP), giving it full ownership. As part of GE HealthCare, NMP, already a leading ...

TOKYO, Oct. 11, 2019 /PRNewswire-PRWeb/ -- Nihon Medi-Physics (NMP), the leading radiopharmaceutical company in Japan, announced the completion of its new research facility on September 10, 2019 ...

TOKYO, Oct. 11, 2019 /PRNewswire-PRWeb/ -- Nihon Medi-Physics (NMP), the leading radiopharmaceutical company in Japan, announced the in-house production of Molybdenum-99 (99Mo), the critical raw ...

Endocyte and Nihon Medi-Physics (NMP) agree to develop and commercialize etarfolatide (EC20) in Japan. EC20 is a companion imaging diagnostic for cancer indications.

Eisai and Nihon Medi-Physics plan to work together on one of Japan's three major dementia types, termed "dementia with Lewy bodies," meaning abnormal massing of protein inside nerve cells. The ...

GE HealthCare (GEHC) has agreed to acquire full ownership of Nihon Medi-Physics, by purchasing from Sumitomo Chemical the 50% stake it does not already own. Sumitomo and GE HealthCare expect the ...